Trial
NCT00585312
Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Adenomatous Polyposis Coli
Intervention
Celecoxib
Why stopped
See termination reason in detailed description.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-21